Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Sep 12 2019 Nemaura Medical to Hold a Symposia at EASD in Barcelona on Thursday September 19, 2019
2. Aug 9 2019 Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019
3. Aug 7 2019 Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch
4. Aug 1 2019 Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors